| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.095 | 0.09 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.09 |